Italian Hospital Pioneers Minimally Invasive Treatment for Supraventricular Arrhythmias
A groundbreaking new treatment offering a high success rate for patients suffering from supraventricular arrhythmias is now available at the Di Venere Hospital in Bari, Italy. The hospital’s cardiology unit, led by Dr. Massimo Vincenzo Bonfantino, has begun performing successful radiofrequency ablation procedures, marking a significant advancement in cardiac care for the region.
The initiative represents a major step forward in treating heart rhythm disorders, offering patients a less invasive alternative to traditional methods. According to a hospital release, the first operation was performed by Dr. Rosanna Valecce, supported by the dedicated medical and nursing team of the Electrophysiology Laboratory. The program’s launch was also facilitated by a collaborative effort with the “Miulli” Hospital of Acquaviva delle Fonti and the expertise of Prof. Massimo Grimaldi, who assisted with training and procedure initiation.
Understanding Supraventricular Arrhythmias
Supraventricular arrhythmias are a common type of heart rhythm disorder characterized by a rapid or irregular heartbeat originating above the ventricles. Symptoms can range from bothersome palpitations, dizziness, and breathlessness to a more alarming sense of an irregular heartbeat. While not always life-threatening, these arrhythmias can significantly diminish a patient’s quality of life and, if left untreated, potentially lead to more serious complications.
The Promise of Radiofrequency Ablation
Radiofrequency ablation has emerged as one of the most effective and durable therapeutic options for these conditions. This minimally invasive procedure involves inserting a catheter, typically through a femoral vein, and carefully guiding it to the heart using advanced three-dimensional electro-anatomical mapping systems.
Through the catheter, cardiologists deliver precisely targeted pulses of radiofrequency energy. This energy creates a controlled thermal effect that interrupts the abnormal electrical pathways responsible for the arrhythmia, effectively restoring a normal heart rhythm. The procedure is typically performed under local anesthesia, lasting between one and two hours, and often allows for same-day or next-day discharge.
Exceptional Outcomes and Improved Quality of Life
The benefits for patients are substantial. Data indicates a definitive resolution of the disorder in 90-95% of cases, significantly reducing the need for long-term antiarrhythmic drugs. Patients experience a rapid recovery and a marked improvement in their overall quality of life.
“With the introduction of this procedure,” explained Dr. Bonfantino, director of the Cardiology Department, “the Cardiology of the “Di Venere” – together with that of the San Paolo hospital – strengthens the ASL’s cardiology network, confirming itself as a point of reference for technological innovation, safety and quality of care in the treatment of arrhythmic pathologies.”
For those affected by supraventricular arrhythmias, this advancement offers a pathway to lasting heart rhythm stability, symptom reduction, and a renewed sense of well-being.
